Table of contents

Extended reports

• Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent (15 March, 2007)

  J Adriaansen, M Khoury, C J de Cortie, F J Fallaux, P Bigey, D Scherman, D J Gould, Y Chernajovsky, F Apparailly, C Jorgensen, M J B M Vervoordeldonk, P P Tak
• Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis (28 March, 2007)

  Frank Behrens, Andrea Himsel, Stefan Rehart, Joanna Stanczyk, Björn Beutel, Stefanie Y Zimmermann, Ulrike Koehl, Burkhard Möller, Steffen Gay, Joachim P Kaltwasser, Josef M Pfeilschifter, Heinfried H Radeke
• Research in hand osteoarthritis: time for reappraisal and demand for new strategies. An opinion paper (14 March, 2007)

  Margreet Kloppenburg, Tanja Stamm, Iain Watt, Franz Kainberger, Tim E Cawston, Fraser N Birrell, Ingemar F Petersson, Tore Saxne, Tore K Kvien, Barbara Slatkowsky-Christensen, Maxime Dougados, Laure Gossec, Ferdinand C Breedveld, Josef S Smolen
• Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

  (7 May, 2007)

  Norihiro Nishimoto, Jun Hashimoto, Nobuyuki Miyasaka, Kazuhiko Yamamoto, Shinichi Kawai, Tsutomu Takeuchi, Norikazu Murata, Désirée van der Heijde, Tadamitsu Kishimoto
• Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) (27 March, 2007)

  Graciela S Alarcón, Gerald McGwin, Ana M Bertoli, Barri J Fessler, Jaime Calvo-Alén, Holly M Bastian, Luis M Vilá, John D Reveille
• Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality (9 January, 2007)

  S A Chambers, S C Charman, A Rahman, D A Isenberg
• Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial (15 March, 2007)

  Matthias Rother, Bernard J Lavins, Werner Kneer, Klaus Lehnhardt, Egbert J Seidel, Stefan Mazgareanu
• Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor? (27 March, 2007)

  Elisabeth Hjardem, Mikkel Østergaard, Jan Pødenphant, Ulrik Tarp, Lis Smedegaard Andersen, Jette Bing, Elisabeth Peen, Hanne Merete Lindegaard, Vibeke Stevenius Ringsdal, Anne Rødgaard, Jens Skøt, Annette Hansen, Hans Henrik Mogensen, Janne Unkerskov, Merete Lund Hetland
• Does knee pain in the community behave like a regional pain syndrome? Prospective cohort study of incidence and persistence (17 November, 2006) Free

  K T Palmer, I Reading, M Calnan, C Linaker, D Coggon
• Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis (28 March, 2007)

  Sigrid Ødegård, Arnstein Finset, Petter Mowinckel, Tore K. Kvien, Till Uhlig
• Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis (15 March, 2007) Free

  A Servettaz, P Guilpain, C Goulvestre, C Chéreau, C Hercend, C Nicco, L Guillevin, B Weill, L Mouthon, F Batteux
• Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency (28 March, 2007)

  D Frezza, V Giambra, B Tolusso, M De Santis, S Bosello, S Vettori, G Triolo, G Valentini, G Ferraccioli
• Introduction of a novel magnetic resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader longitudinal study (28 March, 2007)

  Espen A Haavardsholm, Mikkel Østergaard, Bo J Ejbjerg, Nils P Kvan, Tore K Kvien
• Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan (16 March, 2007)

  Toshihiro Matsui, Yoshiaki Kuga, Atsushi Kaneko, Jinju Nishino, Yoshito Eto, Noriyuki Chiba, Masayuki Yasuda, Koichiro Saisho, Kota Shimada, Shigeto Tohma
• Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial) (3 April, 2007)

  Yvonne P M Goekoop-Ruiterman, Jeska K de Vries-Bouwstra, Cornelia F Allaart, Pit J S M Kerstens, Bernard A M Grillet, Mike H de Jager, K Huub Han, Irene Speyer, Peter A H M van der Lubbe, Patrick E H Seys, Ferdinand C Breedveld, Ben A C Dijkmans
• Double-blinded infliximab dose escalation in patients with rheumatoid arthritis (28 March, 2007) Free

  Mahboob U Rahman, Ingrid Strusberg, Piet Geusens, Alberto Berman, David Yocum, Daniel Baker, Carrie Wagner, John Han, Rene Westhovens
• A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow (5 July, 2007)

  G McKellar, E Morrison, A McEntegart, R Hampson, A Tierney, G Mackle, J Scoular, J A Scott, H A Capell
• Body composition and knee cartilage properties in healthy, community-based adults (29 January, 2007) Free

  Yuanyuan Wang, Anita E Wluka, Dallas R English, Andrew J Teichtahl, Graham G Giles, Richard O’Sullivan, Flavia M Cicuttini